A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin
Condition: Tuberculosis Interventions: Drug: Imatinib; Drug: Isoniazid; Drug: Rifabutin Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Clinical Trials | Gleevec | Hematology | Infectious Diseases | Research | Tuberculosis